Inventurus Knowledge Solutions Q3 FY26 earnings call

IKS Health's acquisition of TruBridge is driven by the vision to create a comprehensive 'platform system of action' deeply integrated with a 'system of record' in the rural hospital market. This integration aims to leverage AI, generative AI, and agentic AI to orchestrate interconnected workflows, moving beyond traditional API-based integration to direct data manipulation within the system of record. This approach is expected to create a significant competitive moat by enabling real-time denial prediction, clinical co-piloting, and the creation of a proprietary AI training corpus, ultimately reducing human involvement and improving outcomes.

TruBridge is a leading provider in the rural hospital market, serving approximately 700 hospitals, which represents over 40% market share in the 0-50 bed segment. These hospitals collectively drive $32 billion in revenue out of a total $164 billion rural hospital market. The market is highly complementary to IKS's traditional ambulatory care focus, as 60-70% of care in rural hospitals is outpatient. TruBridge's RCM business is $220 million, with a total addressable market of $660 million within its install base and a broader $3.5-$4 billion outsourced rural hospital RCM market. Additionally, TruCode, a coding assistance tool, has a $650 million TAM.

The acquisition of TruBridge is valued at an enterprise value of $557 million, comprising $427 million in equity value and $130 million in inherited debt. Pro forma, the combined entity is projected to achieve $698 million in revenue and $186 million in adjusted EBITDA for the trailing 12 months of calendar year 2025. The deal is expected to be instantly EPS accretive by approximately $5 million. While the initial leverage will be "a little over 3x EBITDA," management is confident in rapid deleveraging due to strong cash flow generation and a projected 5x interest coverage on pre-synergy EBITDA.

The acquisition is anticipated to close within 3-4 months (90-120 days), followed by a 4-5 quarter integration process. The initial phase will focus on understanding TruBridge's operating nuances and realizing G&A synergies, which are expected to come in faster than operational synergies. Subsequent phases will involve operational transformation, modernizing TruBridge's EHR to a cloud-native, AI-first architecture, and cross-selling IKS's platform features. IKS aims to achieve INR 3,000 crores EBITDA by FY30 and return net debt levels to near-zero, leveraging its historical 10-year CAGR of 28% revenue and 33% EBITDA.

In the rural EHR market, TruBridge and MEDITECH are dominant incumbents, with Oracle Cerner emerging as a challenger. The RCM market is fragmented, with pure-play BPO vendors like Med-Metrix and CorroHealth. TruCode, IKS's coding assistance tool, competes with larger players like 3M and Optum. IKS's competitive edge stems from its globalized human-in-the-loop delivery model, tech-led approach, and ability to deeply integrate its platform system of action with TruBridge's system of record. This integration enables advanced capabilities like real-time denial prediction and clinical co-piloting, which are crucial for reducing human involvement and improving outcomes.